top of page

PAOG CBD Pharma Development Initiative In Puerto Rico Could Get Boost From COVID-19

"PAOG is currently in discussions in to engage a Contract Research Organization (CRO) in Puerto Rico to advance an Investigational New Drug Application (IND) to ultimately achieve Food and Drug Administration (FDA) approval for PAOG's RespRx as a COPD treatment."

091720 PAOG CBD Pharma Development Initi
Download • 183KB

bottom of page